Adalimumab Effectiveness in Psoriatic Arthritis Trial Study Group. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial - Mease, PJ; Gladman, DD; Ritchlin, CT (Arthritis Rheum, 2005)
et al.